Author:
Xiong Yu-Chao,Wang Jiao,Cheng Yong,Zhang Xin-Yi,Ye Xiao-Qun
Funder
Scientific Research Foundation of the Education Department of Jiangxi Province
Natural Science Foundation of Jiangxi Province
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine
Reference26 articles.
1. Sandberg ML, Sutton SE, Pletcher MT, Wiltshire T, Tarantino LM, Hogenesch JB, Cooke MP (2005) c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation. Dev Cell 8:153–166. https://doi.org/10.1016/j.devcel.2004.12.015
2. Frau M, Ladu S, Calvisi DF, Simile MM, Bonelli P, Daino L, Tomasi ML, Seddaiu MA, Feo F, Pascale RM (2011) Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype. J Hepatol 55:111–119. https://doi.org/10.1016/j.jhep.2010.10.031
3. Ren F, Wang L, Shen X, Xiao X, Liu Z, Wei P, Wang Y, Qi P, Shen C, Sheng W, Du X (2015) MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer. Am J Cancer Res 5:1542–1552
4. Sala A (2012) c-MYB and TGFbeta: EMT's dynamic duo in breast cancer. Cell Cycle 11:17. https://doi.org/10.4161/cc.11.1.18733
5. Chen J, Chen X (2018) MYBL2 is targeted by miR-143-3p and regulates breast cancer cell proliferation and apoptosis. Oncol Res 26:913–922. https://doi.org/10.3727/096504017X15135941182107
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献